As of mid-August 2026, CDC surveillance reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and 47 jurisdictions. This resurgence, the highest since 1989–1991, stems primarily from sustained transmission in under-vaccinated communities, where measles’ basic reproduction number of 12–18 enables rapid spread from imported or lingering 2025 chains. Hospitalizations stand at 7% (169 cases) with zero deaths so far, versus higher rates last year. Weekly CDC case counts and outbreak updates through year-end will shape final totals, while any new vaccination campaigns or school-year transmission shifts could alter trajectories amid ongoing risks to elimination status.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоСлучаи кори в США в 2026 году?
Случаи кори в США в 2026 году?
$7,830,948 Объем
$7,830,948 Объем
31 дек. 2026 г.
↑4,5 тыс.
42%
↑3к
95%
↑3,5 тыс.
93%
↑4k
75%
↑5к
26%
↑7,5 тыс.
12%
↑10k
6%
↑12,5 тыс.
5%
$7,830,948 Объем
$7,830,948 Объем
31 дек. 2026 г.
↑4,5 тыс.
$20 Объем
42%
↑3к
$90,114 Объем
95%
↑3,5 тыс.
$13,530 Объем
93%
↑4k
$220,549 Объем
75%
↑5к
$230,428 Объем
26%
↑7,5 тыс.
$185,031 Объем
12%
↑10k
$6,515,593 Объем
6%
↑12,5 тыс.
$349,917 Объем
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, CDC surveillance reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and 47 jurisdictions. This resurgence, the highest since 1989–1991, stems primarily from sustained transmission in under-vaccinated communities, where measles’ basic reproduction number of 12–18 enables rapid spread from imported or lingering 2025 chains. Hospitalizations stand at 7% (169 cases) with zero deaths so far, versus higher rates last year. Weekly CDC case counts and outbreak updates through year-end will shape final totals, while any new vaccination campaigns or school-year transmission shifts could alter trajectories amid ongoing risks to elimination status.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Feb 16, 2026, 11:51 AM ET
Объем
$7,830,948Дата окончания
31 дек. 2026 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, CDC surveillance reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and 47 jurisdictions. This resurgence, the highest since 1989–1991, stems primarily from sustained transmission in under-vaccinated communities, where measles’ basic reproduction number of 12–18 enables rapid spread from imported or lingering 2025 chains. Hospitalizations stand at 7% (169 cases) with zero deaths so far, versus higher rates last year. Weekly CDC case counts and outbreak updates through year-end will shape final totals, while any new vaccination campaigns or school-year transmission shifts could alter trajectories amid ongoing risks to elimination status.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$7,830,948Дата окончания
31 дек. 2026 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, CDC surveillance reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated across 38 new clusters and 47 jurisdictions. This resurgence, the highest since 1989–1991, stems primarily from sustained transmission in under-vaccinated communities, where measles’ basic reproduction number of 12–18 enables rapid spread from imported or lingering 2025 chains. Hospitalizations stand at 7% (169 cases) with zero deaths so far, versus higher rates last year. Weekly CDC case counts and outbreak updates through year-end will shape final totals, while any new vaccination campaigns or school-year transmission shifts could alter trajectories amid ongoing risks to elimination status.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы